Clinical Study

Hypertension Control and Cardiometabolic Risk: A Regional Perspective

Table 5

Blood pressure and HbA1c (% ± SD, adjusted for age, gender, and diabetes treatment).

Total
( )
Northern Europe
( )
Southern Europe
( )
North America
( )
Middle East
( )
Asia
( )
value

SBP (mmHg)
 <1206.7 (0.115)6.2 (0.202)6.4 (0.199)6.6 (0.214)6.4 (0.725)6.8 (0.257)0.4127
 120–1396.6 (0.047)6.4 (0.072)6.3 (0.081)6.4 (0.113)7.3 (0.348)6.7 (0.114)0.0073
 140–1596.8 (0.037)6.5 (0.049)6.5 (0.062)6.6 (0.111)7.3 (0.168)6.8 (0.102)<0.0001
 160–1796.9 (0.052)6.6 (0.063)6.7 (0.084)6.6 (0.167)7.6 (0.187)6.9 (0.179)<0.0001
 ≥1807.0 (0.084)6.7 (0.102)6.9 (0.135)6.4 (0.402)8.0 (0.243)6.9 (0.292)<0.0001
value<0.00010.00030.00120.47510.68080.7181
DBP (mmHg)
 <906.8 (0.031)6.5 (0.043)6.4 (0.055)6.5 (0.074)7.2 (0.172)6.8 (0.080)<0.0001
 90–996.8 (0.045)6.5 (0.056)6.5 (0.069)6.6 (0.175)7.6 (0.180)6.7 (0.128)<0.0001
 100–1096.9 (0.076)6.6 (0.096)6.8 (0.111)6.4 (0.312)8.0 (0.226)6.4 (0.243)<0.0001
 ≥1106.9 (0.172)6.7 (0.211)6.6 (0.288)7.7 (0.934)7.2 (0.489)7.2 (0.921)0.6603
value0.00270.16050.01360.31900.33320.4885
RR (mmHg)
 uncontrolled*6.8 (0.039)6.5 (0.035)6.6 (0.046)6.6 (0.088)7.6 (0.111)6.8 (0.082)<0.0001
 controlled**6.7 (0.030)6.3 (0.073)6.3 (0.079)6.5 (0.104)7.1 (0.316)6.7 (0.110)0.0075
value<0.00010.00040.00910.24440.33670.3114

*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.